25 (Xinhua) -- Scientists in Australia have developed a simple blood test that detects circulating tumor cells to pinpoint head and neck cancer patients at higher risk of relapse after surgery.
According to a new study, a blood test that detects these molecules could be used to predict who is likely to live longer and guide healthcare decisions accordingly. The rest of this article is behind a paywall.
A simple blood test could help predict who is likely to live longer, according to new research ... a minimally invasive blood test that could identify short‑term survival risk earlier and help guide interventions to promote healthy aging.
New research indicates a simple blood test could detect the deadliest brain tumour in the future ... "Our dual-marker blood test achieved diagnostic accuracy greater than 90 percent and continued to perform just as well when the disease returned.
The happy hour includes a panel discussion with three-time Olympic gold medalist Gabby Thomas, Web Golinkin, President of Babson Diagnostics, and Fred Turner, co-founder and CEO of Curative, and interactive games with Gabby Thomas ....
Earlier work showed that plasma p‑tau217 levels track the same amyloid and tau deposits that imaging reveals, making blood testing a credible proxy ...Food and Drug Administration has cleared the first blood tests to aid in diagnosis.